Two Sigma Investments’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,863
| Closed | -$24.4K | – | 3329 |
|
|
2025
Q1 | $24.4K | Sell |
3,863
-337
| -8% | -$2.13K | ﹤0.01% | 3028 |
|
|
2024
Q4 | $43.3K | Sell |
4,200
-1,451
| -26% | -$15K | ﹤0.01% | 2992 |
|
|
2024
Q3 | $72.6K | Sell |
5,651
-4,166
| -42% | -$53.5K | ﹤0.01% | 2865 |
|
|
2024
Q2 | $136K | Buy |
9,817
+6,142
| +167% | +$85K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $1.14M | Buy |
3,675
+1,023
| +39% | +$318K | ﹤0.01% | 1810 |
|
|
2023
Q4 | $695K | Buy |
2,652
+2,324
| +709% | +$609K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $64.2K | Buy |
+328
| New | +$64.2K | ﹤0.01% | 2714 |
|
|
2022
Q3 | – | Sell |
-270
| Closed | -$76K | – | 2614 |
|
|
2022
Q2 | $76K | Buy |
+270
| New | +$76K | ﹤0.01% | 2232 |
|
|
2022
Q1 | – | Sell |
-355
| Closed | -$77K | – | 2880 |
|
|
2021
Q4 | $77K | Buy |
355
+87
| +32% | +$18.9K | ﹤0.01% | 2435 |
|
|
2021
Q3 | $122K | Sell |
268
-210
| -44% | -$95.6K | ﹤0.01% | 2372 |
|
|
2021
Q2 | $192K | Sell |
478
-963
| -67% | -$387K | ﹤0.01% | 2234 |
|
|
2021
Q1 | $835K | Buy |
1,441
+991
| +220% | +$574K | ﹤0.01% | 1670 |
|
|
2020
Q4 | $257K | Buy |
+450
| New | +$257K | ﹤0.01% | 1773 |
|
|
2020
Q3 | – | Sell |
-412
| Closed | -$234K | – | 2161 |
|
|
2020
Q2 | $234K | Buy |
+412
| New | +$234K | ﹤0.01% | 1694 |
|